Optimi Health Corp. (OPTH) — Optimi Health closed an oversubscribed US$15 million underwritten public offering tied to the uplisting of its common shares to the Nasdaq Capital Market, issuing 2.4 million shares at US$6.25 each.
The shares began trading on Nasdaq under the ticker OPTH on May 20, 2026, with the offering closing on May 21. The uplisting and fresh capital strengthen the commercial-stage psilocybin manufacturer's access to U.S. investors as it scales exports to Australia and prepares clinical-trial supply.
Source: investingnews.com
For the rest of that week's sector news, read our week in review.